Exact Mass: 420.1268
Exact Mass Matches: 420.1268
Found 130 metabolites which its exact mass value is equals to given mass value 420.1268
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Flurbiprofen glucuronide
Flurbiprofen glucuronide is a metabolite of flurbiprofen. Flurbiprofen is a member of the phenylalkanoic acid derivative family of non-steroidal anti-inflammatory drugs (NSAIDs) used to treat the inflammation and pain of arthritis. It is known by the following tradenames: Urbifen marketed by General Pharmaceuticals, Ansaid, marketed by Pfizer, Flurwood by W. Woodward and Froben, by Abbott. Flurbiprofen is also used as an active ingredient in some kinds of throat lozenges. (Wikipedia)
Etofylline clofibrate
10-Chloro-1-[(3S)-3-hydroxypyrrolidine-1-carbonyl]-3-phenyl-6,7-dihydrobenzo[a]quinolizin-4-one
Sesamoside
Sesamoside is a natural product found in Pedicularis muscicola, Phlomoides umbrosa, and other organisms with data available. Sesamoside is a iridoid isolated from the aerial part of? Lamiophlomis rotata. Sesamoside has antiodant and antiglycation activities[1]. Sesamoside is a iridoid isolated from the aerial part of? Lamiophlomis rotata. Sesamoside has antiodant and antiglycation activities[1].
5-O-methylhoslundin
Glabratephrin
2-methyl-4-oxo-4H-pyran-3-yl 2-O-(beta-D-apiofuranosyl)-beta-D-glucopyranoside|3-O-[beta-D-apiofuranosyl-(1?2)-beta-D-glucopyranosyl]maltol
(-)-3-hydoxy-2-methyl-4-pyrone 3-O-beta-D-xylopyranosyl-(1?6)-O-beta-D-glucopyranoside
C17H24O12_4H-Pyran-4-one, 2-methyl-3-[[6-O-[(2R,3R,4R)-tetrahydro-3,4-dihydroxy-4-(hydroxymethyl)-2-furanyl]-beta-D-glucopyranosyl]oxy]
3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-methylpyran-4-one
3-[(2S,3R,4S,5S,6R)-6-[[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-2-methylpyran-4-one_major
Cys Asp Pro Ser
Cys Asp Ser Pro
Cys Pro Asp Ser
Cys Pro Ser Asp
Cys Ser Asp Pro
Cys Ser Pro Asp
Asp Cys Pro Ser
Asp Cys Ser Pro
Asp Pro Cys Ser
Asp Pro Ser Cys
Asp Ser Cys Pro
Asp Ser Pro Cys
Pro Cys Asp Ser
Pro Cys Ser Asp
Pro Asp Cys Ser
Pro Asp Ser Cys
Pro Ser Cys Asp
Pro Ser Asp Cys
Ser Cys Asp Pro
Ser Cys Pro Asp
Ser Asp Cys Pro
Ser Asp Pro Cys
Ser Pro Cys Asp
Ser Pro Asp Cys
2-Methyl-4-oxo-4H-pyran-3-yl 6-O-[(2R,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-?-D-glucopyranoside
Benzyloxycarbonyl-L-phenylalanine p-nitrophenylester
1-Methyl-3-(1-methylpiperidin-4-yl)-1H-indol-5-yl 2,6-difluorobenzenesulfonate
2-[3-[4-(3-chloro-4-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypropylamino]ethanol
etofylline clofibrate
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D020011 - Protective Agents > D000975 - Antioxidants D009676 - Noxae > D000963 - Antimetabolites D011838 - Radiation-Sensitizing Agents
Anzemet (TN)
D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents
3-(1,4,7,10-Tetraazacyclododec-1-yl)-1,2,4-butanetriol hydrochloride (1:4)
(S)-Flurbiprofen-acyl-beta-D-glucuronide min. 98\\%
Flurbiprofen Acyl-β-D-glucuronide (Mixture of Diastereomers)
3-(3,4-Dimethylphenyl)sulfonyl-2-imino-1-prop-2-enyl-5-dipyrido[1,2-e:4,3-f]pyrimidinone
10-Chloro-1-[(3S)-3-hydroxypyrrolidine-1-carbonyl]-3-phenyl-6,7-dihydrobenzo[a]quinolizin-4-one
N-(3-anilino-2-quinoxalinyl)-4-ethoxybenzenesulfonamide
Methyl 2-[(1-ethylpyrazole-4-carbonyl)carbamothioylamino]-4,5,6,7,8,9-hexahydrocycloocta[b]thiophene-3-carboxylate
N-(1H-benzimidazol-2-yl)-3-[methyl-(4-methylphenyl)sulfamoyl]benzamide
N-(3-acetylphenyl)-2-[(7-methoxy-4-methyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]acetamide
N-(5-tert-butyl-3-isoxazolyl)-7-chloro-8-methyl-2-(2-pyridinyl)-4-quinolinecarboxamide
3-[[1-Oxo-2-[(4,6,9-trimethyl-[1,2,4]triazolo[4,3-a]quinolin-1-yl)thio]ethyl]amino]benzoic acid
(2S,3S,4S,5R,6S)-6-[2-(3-fluoro-4-phenylphenyl)propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
4-(4-Methoxybenzoyl)-5-(2-methoxyphenyl)-1-(5-methyl-1,2-oxazol-3-yl)pyrrolidine-2,3-dione
[4-[1-Hydroxy-3-(5-methoxy-2,2-dimethylchromen-6-yl)propyl]phenyl] hydrogen sulate
4-(3-Chloro-4-fluoroanilino)-6-[3-(3-hydroxypropylamino)propoxy]quinazolin-7-ol
AMPK activator 4
AMPK activator 4 is a potent AMPK activator without inhibition of mitochondrial complex I. AMPK activator 4 selectively activates AMPK in the muscle tissues. AMPK activator 4 dose-dependently improves glucose tolerance in normal mice, and significantly lowers fasting blood glucose level and ameliorates insulin resistance in db/db diabetic mice. Anti-hyperglycemic effect[1].
KRAS G12D inhibitor 14
KRAS G12D inhibitor 14 is a potent KRAS G12D inhibitor with a KD of 33 nM for binding to KRAS G12D protein. KRAS G12D inhibitor 14 decreases the active form of KRAS G12D (KRAS G12D-GTP) but not KRAS G13D[1].
10-acetyl-21-hydroxy-6,6,17,17-tetramethyl-7,12,18-trioxapentacyclo[11.8.0.0³,¹¹.0⁵,⁹.0¹⁴,¹⁹]henicosa-1(21),3,5(9),10,13,15,19-heptaene-2,8-dione
methyl (1s,2r,4s,5r,6r,10s)-5,6-dihydroxy-2-methyl-10-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-ene-7-carboxylate
methyl (1s,2r,4s,5r,6r,10s)-5,6-dihydroxy-2-methyl-10-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,9-dioxatricyclo[4.4.0.0²,⁴]dec-7-ene-7-carboxylate
(1s,4as,6s,7r,7as)-6-hydroxy-4-(methoxycarbonyl)-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,6h,7h,7ah-cyclopenta[c]pyran-7-carboxylic acid
3-{[(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-2-methylpyran-4-one
(4'r,9s)-5',5'-dimethyl-2',4-dioxo-2-phenyl-8h-spiro[furo[2,3-h]chromene-9,3'-oxolan]-4'-yl acetate
methyl (1s,2s,3s,7s,9s,11r)-11-hydroxy-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-4,10,12-trioxatricyclo[7.2.1.0²,⁷]dodec-5-ene-6-carboxylate
(19s)-19-ethyl-7-methoxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl acetate
10-methoxy-20-o-acetylcamptothecin
{"Ingredient_id": "HBIN000160","Ingredient_name": "10-methoxy-20-o-acetylcamptothecin","Alias": "NA","Ingredient_formula": "C23H20N2O6","Ingredient_Smile": "CCC1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)OC)OC(=O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13824","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
6beta,7beta-epoxy-8-epi-splendoside
{"Ingredient_id": "HBIN012244","Ingredient_name": "6beta,7beta-epoxy-8-epi-splendoside","Alias": "NA","Ingredient_formula": "C17H24O12","Ingredient_Smile": "COC(=O)C1=COC(C2C1C3C(C2(CO)O)O3)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "420.4 g/mol","OB_score": "11.85768748","CAS_id": "NA","SymMap_id": "SMIT10651","TCMID_id": "NA","TCMSP_id": "MOL009532","TCM_ID_id": "NA","PubChem_id": "11166049","DrugBank_id": "NA"}